ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,059Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 5176

$979K Total Retail Price of All Prescriptions

Rank: 278 out of 5176

603 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 603 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 16,190 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 1,771 1,521 1 2
SIMVASTATIN 958 794 2 1
METFORMIN HCL 797 693 3 7
OMEPRAZOLE 794 623 4 3
DIOVAN 681 602 5 19
LEVOTHYROXINE SODIUM 633 503 6 4
METOPROLOL SUCCINATE 487 446 7 11
ENALAPRIL MALEATE 443 365 8 22
METOPROLOL TARTRATE 425 370 9 6
LOSARTAN POTASSIUM 405 346 10 14
JANUVIA 376 287 11 25
HYDROCHLOROTHIAZIDE 349 313 12 10
CRESTOR 304 265 13 15
NEXIUM 283 246 14 16
RANITIDINE HCL 263 229 15 36
TAMSULOSIN HCL 248 233 16 20
FUROSEMIDE 248 234 16 8
WARFARIN SODIUM 247 227 18 13
ALENDRONATE SODIUM 245 209 19 18
CLOPIDOGREL 236 207 20 26
IBUPROFEN 229 180 21 72
CLOTRIMAZOLE-BETAMETHASONE 215 195 22 94
LISINOPRIL 211 151 23 5
PLAVIX 201 180 24 29
ATENOLOL 184 156 25 12
LANTUS 182 146 26 66
ZOLPIDEM TARTRATE 180 178 27 17
GLIPIZIDE XL 179 163 28 83
ATORVASTATIN CALCIUM 169 136 29 9
MICARDIS 167 141 30 154
VENTOLIN HFA 166 105 31 64
PROAIR HFA 166 132 31 60
GLIMEPIRIDE 161 132 33 37
GABAPENTIN 161 139 33 21
SINGULAIR 140 98 35 62
CARVEDILOL 140 130 35 24
LOVAZA 137 121 37 43
POLYETHYLENE GLYCOL 3350 137 103 37 74
ISOSORBIDE MONONITRATE ER 128 120 39 44
HYDROCORTISONE VALERATE 119 115 40 319
ZETIA 116 101 41 68
GLIPIZIDE 109 96 42 63
FAMOTIDINE 108 89 43 58
ADVAIR DISKUS 106 101 44 32
INSULIN SYRINGE 99 85 45 137
GLYBURIDE 96 67 R 46 67
MECLIZINE HCL 95 87 47 81
GLYBURIDE-METFORMIN HCL 95 69 R 47 76
PRAVASTATIN SODIUM 91 80 49 23
TRAMADOL HCL 89 73 50 40
NAPROXEN 88 76 51 95
CELEBREX 88 68 51 80
GLIPIZIDE ER 84 80 53 117
DILTIAZEM 24HR CD 82 72 54 119
TEKTURNA 80 80 55 255
NITROGLYCERIN PATCH 79 75 56 149
NIFEDIPINE ER 78 78 57 48
AZITHROMYCIN 73 61 58 42
LOSARTAN-HYDROCHLOROTHIAZIDE 67 52 59 35
CITALOPRAM HBR 65 54 60 31
DONEPEZIL HCL 61 60 61 28
AMLODIPINE BESYLATE-BENAZEPRIL 59 44 62 55
MONTELUKAST SODIUM 58 44 63 123
PREDNISONE 58 57 63 52
VYTORIN 58 58 63 152
LIPITOR 55 54 66 51
SYNTHROID 53 49 67 33
RAMIPRIL 52 52 68 50
LANTUS SOLOSTAR 51 49 69 70
SERTRALINE HCL 51 46 69 30
GEMFIBROZIL 51 29 69 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.